Skip to main content
Top
Published in: BMC Infectious Diseases 1/2009

Open Access 01-12-2009 | Research article

Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998–2004)

Authors: Angel Gil, Ruth Gil, Alejendro Alvaro, María San Martín, Antonio González

Published in: BMC Infectious Diseases | Issue 1/2009

Login to get access

Abstract

Background

A thorough epidemiological surveillance and a good understanding of the burden of diseases associated to VZV are crucial to asses any potential impact of a prevention strategy. A population-based retrospective epidemiological study to estimate the burden of herpes zoster requiring hospitalization in Spain was conducted.

Methods

This study was conducted by using data from the national surveillance system for hospital data, Conjunto Mínimo Básico de Datos (CMBD). Records of all patients admitted to hospital with a diagnosis of herpes zoster (ICD-9-MC codes 053.0–053.9) during a 7-year period (1998–2004) were selected.

Results

A total of 23,584 hospitalizations with a primary or secondary diagnosis of herpes zoster in patients ≥ 30 years of age were identified during the study period. Annually there were 13.4 hospitalizations for herpes zoster per 100,000 population in patients ≥ 30 years of age. The rate increases with age reaching a maximum in persons ≥ 80 years of age (54.3 admissions per 100,000 population >80 years of age). The mean cost of a hospitalization for herpes zoster in adult patients was 3,720 €. The estimated annual cost of hospitalizations for herpes zoster in patients ≥ 30 years of age in Spain was 12,731,954 €.

Conclusion

Herpes zoster imposes an important burden of hospitalizations and result in large cost expenses to the Spanish National Health System, especially in population older than 50 years of age
Appendix
Available only for authorised users
Literature
1.
go back to reference Vázquez M, Shapiro ED: Varicella vaccine and infection with varicella-zoster virus. N Engl J Med. 2005, 352 (5): 439-40. 10.1056/NEJMp048320.CrossRefPubMed Vázquez M, Shapiro ED: Varicella vaccine and infection with varicella-zoster virus. N Engl J Med. 2005, 352 (5): 439-40. 10.1056/NEJMp048320.CrossRefPubMed
2.
go back to reference Galil K, Choo PW, Donahue JG, Platt R: The sequelae of herpes zoster. Arch Intern Med. 1997, 157 (11): 1209-13. 10.1001/archinte.157.11.1209.CrossRefPubMed Galil K, Choo PW, Donahue JG, Platt R: The sequelae of herpes zoster. Arch Intern Med. 1997, 157 (11): 1209-13. 10.1001/archinte.157.11.1209.CrossRefPubMed
4.
go back to reference Edmunds WJ, Brisson M, Rose JD: The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine. 2001, 19 (23–24): 3076-90. 10.1016/S0264-410X(01)00044-5.CrossRefPubMed Edmunds WJ, Brisson M, Rose JD: The epidemiology of herpes zoster and potential cost-effectiveness of vaccination in England and Wales. Vaccine. 2001, 19 (23–24): 3076-90. 10.1016/S0264-410X(01)00044-5.CrossRefPubMed
5.
go back to reference Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA: Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ. 2000, 321 (7264): 794-6. 10.1136/bmj.321.7264.794.CrossRefPubMedPubMedCentral Helgason S, Petursson G, Gudmundsson S, Sigurdsson JA: Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. BMJ. 2000, 321 (7264): 794-6. 10.1136/bmj.321.7264.794.CrossRefPubMedPubMedCentral
6.
go back to reference De Moragas JM, Kierland RR: The outcome of patients with herpes zoster. AMA Arch Derm. 1957, 75 (2): 193-6.CrossRefPubMed De Moragas JM, Kierland RR: The outcome of patients with herpes zoster. AMA Arch Derm. 1957, 75 (2): 193-6.CrossRefPubMed
7.
go back to reference Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Shingles Prevention Study Group, et al: A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005, 352 (22): 2271-84. 10.1056/NEJMoa051016.CrossRefPubMed Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Shingles Prevention Study Group, et al: A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005, 352 (22): 2271-84. 10.1056/NEJMoa051016.CrossRefPubMed
8.
go back to reference Lin F, Hadler JL: Epidemiology of primary varicella and herpes zoster hospitalisations: the pre-vaccination era. J Infect Dis. 2000, 181: 1897-905. 10.1086/315492.CrossRefPubMed Lin F, Hadler JL: Epidemiology of primary varicella and herpes zoster hospitalisations: the pre-vaccination era. J Infect Dis. 2000, 181: 1897-905. 10.1086/315492.CrossRefPubMed
13.
go back to reference Gil A, San-Martín M, Carrasco P, González A: Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine. 2004, 22: 3947-51. 10.1016/j.vaccine.2004.04.004.CrossRefPubMed Gil A, San-Martín M, Carrasco P, González A: Epidemiology of severe varicella-zoster virus infection in Spain. Vaccine. 2004, 22: 3947-51. 10.1016/j.vaccine.2004.04.004.CrossRefPubMed
14.
go back to reference Gil A, Carrasco P, Jiménez R, San-Martín M, Oyagüez I, González A: Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999–2000. Vaccine. 2004, 22: 2221-2225. 10.1016/j.vaccine.2003.11.037.CrossRefPubMed Gil A, Carrasco P, Jiménez R, San-Martín M, Oyagüez I, González A: Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999–2000. Vaccine. 2004, 22: 2221-2225. 10.1016/j.vaccine.2003.11.037.CrossRefPubMed
15.
go back to reference Gil A, San-Martín M, Carrasco P, González A: Epidemiology of pneumonia hospitalizations in Spain, 1995–1998. Journal of infection. 2002, 44: 84-87. 10.1053/jinf.2002.0966.CrossRefPubMed Gil A, San-Martín M, Carrasco P, González A: Epidemiology of pneumonia hospitalizations in Spain, 1995–1998. Journal of infection. 2002, 44: 84-87. 10.1053/jinf.2002.0966.CrossRefPubMed
16.
go back to reference Penberthy L, McClish D, Pugh A, Smith W, Manning C, Retchin S: Using hospital discharge files to enhance cancer surveillance. Am J Epidemiol. 2003, 158: 27-34. 10.1093/aje/kwg108.CrossRefPubMed Penberthy L, McClish D, Pugh A, Smith W, Manning C, Retchin S: Using hospital discharge files to enhance cancer surveillance. Am J Epidemiol. 2003, 158: 27-34. 10.1093/aje/kwg108.CrossRefPubMed
17.
go back to reference Middleton RJ, Gavin AT, Reid JS, O'Reilly D: Accuracy of hospital discharge data for cancer registration and epidemiological research in Northern Ireland. Cancer Causes Control. 2000, 11: 899-905. 10.1023/A:1026543100223.CrossRefPubMed Middleton RJ, Gavin AT, Reid JS, O'Reilly D: Accuracy of hospital discharge data for cancer registration and epidemiological research in Northern Ireland. Cancer Causes Control. 2000, 11: 899-905. 10.1023/A:1026543100223.CrossRefPubMed
19.
go back to reference Schreyögg J, Stargardt T, Tiemann O, Busse R: Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries. Health Care Manag Sci. 2006, 3: 215-23. 10.1007/s10729-006-9040-1.CrossRef Schreyögg J, Stargardt T, Tiemann O, Busse R: Methods to determine reimbursement rates for diagnosis related groups (DRG): a comparison of nine European countries. Health Care Manag Sci. 2006, 3: 215-23. 10.1007/s10729-006-9040-1.CrossRef
20.
go back to reference Huff L, Bogdan G, Burke K, Hayes E, Perry W, Graham L, Lentzner H: Using hospital discharge data for disease surveillance. Public Health Rep. 1996, 111: 78-81.PubMedPubMedCentral Huff L, Bogdan G, Burke K, Hayes E, Perry W, Graham L, Lentzner H: Using hospital discharge data for disease surveillance. Public Health Rep. 1996, 111: 78-81.PubMedPubMedCentral
21.
go back to reference Galil K, Brown C, Lin F, Seward J: Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J. 2002, 21 (10): 931-5. 10.1097/00006454-200210000-00009.CrossRefPubMed Galil K, Brown C, Lin F, Seward J: Hospitalizations for varicella in the United States, 1988 to 1999. Pediatr Infect Dis J. 2002, 21 (10): 931-5. 10.1097/00006454-200210000-00009.CrossRefPubMed
22.
go back to reference Miller E, Marshall R, Verdien J: Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol. 1993, 4: 222-30.CrossRef Miller E, Marshall R, Verdien J: Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol. 1993, 4: 222-30.CrossRef
23.
go back to reference Brisson M, Edmunds WJ: Epidemiology of Varicella-Zoster Virus in England and Wales. J Med Virol. 2003, 70 (Suppl 1): S9-14. 10.1002/jmv.10313.CrossRefPubMed Brisson M, Edmunds WJ: Epidemiology of Varicella-Zoster Virus in England and Wales. J Med Virol. 2003, 70 (Suppl 1): S9-14. 10.1002/jmv.10313.CrossRefPubMed
25.
go back to reference Bramley JC, Jones IG: Epidemiology of chickenpox in Scotland: 1981 to 1998. Commun Dis Public Health. 2000, 3 (4): 282-7.PubMed Bramley JC, Jones IG: Epidemiology of chickenpox in Scotland: 1981 to 1998. Commun Dis Public Health. 2000, 3 (4): 282-7.PubMed
26.
go back to reference Koskiniemi M, Piiparinen H, Rantalaiho T, Eranko P, Farkkila M, Raiha K, Salonen EM, Ukkonen P, Vaheri A: Acute central nervous system complications in varicella zoster virus infections. J Clin Virol. 2002, 25 (3): 293-301. 10.1016/S1386-6532(02)00020-3.CrossRefPubMed Koskiniemi M, Piiparinen H, Rantalaiho T, Eranko P, Farkkila M, Raiha K, Salonen EM, Ukkonen P, Vaheri A: Acute central nervous system complications in varicella zoster virus infections. J Clin Virol. 2002, 25 (3): 293-301. 10.1016/S1386-6532(02)00020-3.CrossRefPubMed
Metadata
Title
Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998–2004)
Authors
Angel Gil
Ruth Gil
Alejendro Alvaro
María San Martín
Antonio González
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2009
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-9-55

Other articles of this Issue 1/2009

BMC Infectious Diseases 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.